Other

Gain on sale of Telavant net assets

Over 2 years (FY 2023 to FY 2025), Gain on sale of Telavant net assets shows a downward trend with a -100.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementIncome Statement
SectionOther
CategoryOther
SignalHigher is better
VolatilityVolatile
First reportedQ3 2022
Last reportedQ4 2025May 20, 2026

How to read this metric

A gain indicates successful monetization of assets, while a loss may suggest divestment under unfavorable conditions.

Detailed definition

This metric captures the net financial impact from the divestiture of specific business units or significant assets. It...

Peer comparison

Non-recurring item; peers are evaluated on the strategic rationale behind such divestitures.

Metric ID: other_gain_loss_on_sale_of_assets

Historical Data

14 periods
 Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$0.00$0.00$0.00$0.00$5.35B$0.00$110.39M$0.00$0.00$0.00$0.00$0.00$0.00$0.00
QoQ Change-100.0%-100.0%
YoY Change-100.0%-100.0%
Range$0.00$5.35B
Avg YoY Growth-100.0%
Median YoY Growth-100.0%

Business Segments

View all
SegmentQ1 '25Q2 '25Q3 '25Q4 '25
Reportable Segment$0.00$0.00$0.00$0.00
Total$0.00$0.00$0.00$0.00

Frequently Asked Questions

What is Roivant Sciences's gain on sale of telavant net assets?
Roivant Sciences (ROIV) reported gain on sale of telavant net assets of $0.00 in Q1 2026.
What is the long-term trend for Roivant Sciences's gain on sale of telavant net assets?
Over 2 years (2023 to 2025), Roivant Sciences's gain on sale of telavant net assets has grown at a -100.0% compound annual growth rate (CAGR), from $5.35B to $0.00.
What does gain on sale of telavant net assets mean?
Profit or loss realized from selling off a business unit or major asset.